{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:43:23Z","timestamp":1789717403565,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.spinee.2013.10.020","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T05:36:16Z","timestamp":1383284176000},"page":"e13-e19","source":"Crossref","is-referenced-by-count":7,"title":["Multiple myeloma exacerbation following utilization of bone morphogenetic protein-2 in lateral lumbar interbody fusion: a case report and review of the literature"],"prefix":"10.1016","volume":"14","author":[{"given":"Alexander P.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazda","family":"Farshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Aichmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2013.10.020_bib1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.spinee.2013.10.020_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2009.956","article-title":"Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures","volume":"302","author":"Cahill","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.spinee.2013.10.020_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2106\/JBJS.G.01485","article-title":"Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2","volume":"91","author":"Burkus","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2013.10.020_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002517-199804000-00001","article-title":"Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage","volume":"11","author":"Boden","year":"1998","journal-title":"J\u00a0Spinal Disord"},{"key":"10.1016\/j.spinee.2013.10.020_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00007632-199904010-00004","article-title":"The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model","volume":"24","author":"Hecht","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2013.10.020_bib7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1097\/BRS.0b013e318190705d","article-title":"RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age","volume":"33","author":"Glassman","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3171\/spi.2005.2.5.0521","article-title":"Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein","volume":"2","author":"Boakye","year":"2005","journal-title":"J Neurosurg Spine"},{"issue":"9 Suppl","key":"10.1016\/j.spinee.2013.10.020_bib9","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/BRS.0b013e3181d81ef2","article-title":"Complications related to osteobiologics use in spine surgery: a systematic review","volume":"35","author":"Mroz","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/BRS.0b013e3181ce11cc","article-title":"Complications and concerns with osteobiologics for spine fusion in clinical practice","volume":"35","author":"Glassman","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/BRS.0b013e3181d133d0","article-title":"Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: a consecutive series of 1037 cases","volume":"36","author":"Glassman","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.spinee.2007.06.014","article-title":"Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF\/TLIF use of bone morphogenetic protein-2 (BMP-2)","volume":"8","author":"Wong","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3171\/2009.4.SPINE0876","article-title":"Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion","volume":"12","author":"Chen","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2013.10.020_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.spinee.2013.07.073","article-title":"Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study","author":"Lykissas","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.spinee.2013.07.473","article-title":"Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion","volume":"13","author":"Aichmair","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.spinee.2012.11.052","article-title":"Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation","volume":"13","author":"Taher","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.spinee.2010.07.005","article-title":"Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2\u2014but what is the cost?","volume":"11","author":"Mannion","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","article-title":"Bone morphogenetic proteins and cancer: review of the literature","volume":"66","author":"Thawani","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2013.10.020_bib22","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/sj.onc.1209393","article-title":"Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells","volume":"25","author":"Fukuda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.spinee.2013.10.020_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V97.2.516","article-title":"Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells","volume":"97","author":"Hjertner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.spinee.2013.10.020_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2011.263","article-title":"Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by smad-dependent repression of MYC","volume":"26","author":"Holien","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.spinee.2013.10.020_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10428190290012182","article-title":"Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells","volume":"43","author":"Kawamura","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.spinee.2013.10.020_bib26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V96.6.2005","article-title":"Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3","volume":"96","author":"Kawamura","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.spinee.2013.10.020_bib27","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/sj.onc.1207386","article-title":"Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells","volume":"23","author":"Ro","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.spinee.2013.10.020_bib28","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2009.257","article-title":"Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis","volume":"28","author":"Seckinger","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.spinee.2013.10.020_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.spinee.2005.08.012","article-title":"Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion","volume":"6","author":"Ozgur","year":"2006","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.10.020_bib30","unstructured":"Food and Drug Administration (FDA). Executive summary for P050036 Medtronic's AMPLIFY\u2122 rhBMP-2 matrix; Orthopaedic and Rehabilitation Devices Advisory Panel. 2010. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/MedicalDevices\/MedicalDevicesAdvisoryCommittee\/OrthopaedicandRehabilitationDevicesPanel\/UCM220079.pdf. Accessed March 19,\u00a02013."},{"key":"10.1016\/j.spinee.2013.10.020_bib31","unstructured":"Food and Drug Administration (FDA). Summary of safety and effectiveness data for P000058 Medtronic's InFUSE\u2122 Bone Graft\/LT-CAGE\u2122 lumbar tapered fusion device; Orthopaedic and Rehabilitation Devices Advisory Panel. 2002. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P000058b.pdf. Accessed April 15, 2013."},{"key":"10.1016\/j.spinee.2013.10.020_bib32","unstructured":"Kelly MP, Savage JW, Bentzen SM, et\u00a0al. Cancer risk from recombinant human bone morphogenetic protein-2 exposure in spinal fusion. Paper presented at: 2013 Annual Meeting of the Lumbar Spine Research Society; April 11\u201312, 2013; Chicago, IL. Available at: http:\/\/thejns.org\/doi\/pdf\/10.3171\/2013.4.FOC-LSRSabstracts. Accessed April 15,\u00a02013."},{"key":"10.1016\/j.spinee.2013.10.020_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0031-1298616","article-title":"The use of rhBMP in spine surgery: is there a cancer risk?","volume":"3","author":"Devine","year":"2012","journal-title":"Evid Based Spine Care J"},{"key":"10.1016\/j.spinee.2013.10.020_bib34","unstructured":"Howlader N, Noone AM, Krapcho M, et\u00a0al. SEER cancer statistics review, 1975-2009 (Vintage 2009 populations). Updated August 20, 2012. Bethesda, MD: National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/. Based on November 2011 SEER data submission, posted to the SEER Web site, April\u00a02012. Accessed December 3, 2013."}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152994301301615X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152994301301615X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T06:26:57Z","timestamp":1596781617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152994301301615X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S152994301301615X"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2013.10.020","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}